Results 91 to 100 of about 1,532,463 (338)

Natural course of cannabis use disorders [PDF]

open access: yesPsychological Medicine, 2014
BackgroundDespite its importance as a public health concern, relatively little is known about the natural course of cannabis use disorders (CUDs). The primary objective of this research was to provide descriptive data on the onset, recovery and recurrence functions of CUDs during the high-risk periods of adolescence, emerging adulthood and young ...
Farmer, R. F.   +7 more
openaire   +3 more sources

Treatment of Adolescent Cannabis Use Disorders

open access: yesChild and Adolescent Psychiatric Clinics of North America, 2023
This review summarizes treatments for cannabis use disorder (CUD) in adolescents. The best supported CUD treatments are cognitive behavioral psychotherapies, including family-based models that facilitate environmental changes and youth-focused models that incorporate skills training, motivational interviewing, and contingency management to promote ...
Adams, Zachary W.   +3 more
openaire   +3 more sources

Recent Perspectives on Phytochemical Profile, Pharmacological Activities, and Industrial Applications of Guava (Psidium guajava)

open access: yesFood Safety and Health, EarlyView.
Psidium guajava leaves contain potent bioactive compounds like quercetin, myricetin, and triterpenoids that show antioxidant, antidiabetic, anti‐inflammatory, and anticancer effects. They act by modulating NF‐κB, PPARγ, and α‐glucosidase and by inducing apoptosis and cell cycle arrest.
Muhammad Waqar   +10 more
wiley   +1 more source

Factors associated with lower-risk cannabis use in adults in their mid-thirties

open access: yesJournal of Cannabis Research
Background Harm reduction strategies encourage people who use cannabis to adopt lower-risk behaviors, such as refraining from daily or intensive use or limiting simultaneous use with other psychoactive substances.
Guillaume Dubé   +4 more
doaj   +1 more source

Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis

open access: yesFrontiers in Public Health
BackgroundAs the most commonly used illicit substance, cannabis is gaining global acceptance through increasing legalization efforts. This shift intensifies the need for research to guide policymakers and healthcare providers in harm reduction and ...
Christoph Felix Mosandl   +9 more
doaj   +1 more source

The Use of Cannabis as a Predictor of Early Onset of Bipolar Disorder and Suicide Attempts

open access: yesNeural Plasticity, 2015
Introduction. Bipolar disorder (BD) implies risk of suicide. The age at onset (AAO) of BD carries prognostic significance. Substance abuse may precede the onset of BD and cannabis is the most common illicit drug used.
Rafaela Torres Portugal Leite   +8 more
doaj   +1 more source

Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder

open access: yesFrontiers in Psychiatry, 2021
The treatment of patients with schizophrenia and substance use disorder poses a challenge for clinicians. Continued use of cannabis and cocaine can exacerbate psychotic symptoms and worsen the course of disease.
Maximilian Meyer   +5 more
doaj   +1 more source

New vistas on cannabis use disorder [PDF]

open access: yesNeuropharmacology, 2017
Cannabis sativa preparations are the most consumed illicit drugs for recreational purposes worldwide, and the number of people seeking treatment for cannabis use disorder has dramatically increased in the last decades. Due to the recent decriminalization or legalization of cannabis use in the Western Countries, we may predict that the number of people ...
MELIS, MIRIAM   +7 more
openaire   +3 more sources

Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review

open access: yesJournal of Clinical Medicine, 2020
Background: The landscape of attitudes, legal status and patterns of use of cannabis is rapidly changing in the United States and elsewhere. Therefore, the primary aim of this narrative review is to provide a concise overview of the literature on the ...
D. Hasin, C. Walsh
semanticscholar   +1 more source

Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy

open access: yesIbrain, Volume 11, Issue 1, Page 44-58, Spring 2025.
In the central nervous system, activated immune cells lead to the overproduction of inflammatory mediators through the corresponding signal pathway. Under the stimulation of inflammatory factors, neuroinflammation ultimately occurs. Overexpression of inflammatory mediators and activated immunocytes plays an important role in the emergence and ...
Yue Yu, Fei‐Ji Sun
wiley   +1 more source

Home - About - Disclaimer - Privacy